- Home
- MNMD vs FBIZ Comparison
MNMD vs FBIZ Comparison
Compare MNMD & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNMD
- FBIZ
- Stock Information
- Founded
- MNMD 2019
- FBIZ 1909
- Country
- MNMD United States
- FBIZ United States
- Employees
- MNMD N/A
- FBIZ N/A
- Industry
- MNMD Pharmaceuticals and Biotechnology
- FBIZ Major Banks
- Sector
- MNMD Health Care
- FBIZ Finance
- Exchange
- MNMD Nasdaq
- FBIZ Nasdaq
- Market Cap
- MNMD 509.2M
- FBIZ 446.6M
- IPO Year
- MNMD N/A
- FBIZ N/A
- Fundamental
- Price
- MNMD $9.76
- FBIZ $48.59
- Analyst Decision
- MNMD Strong Buy
- FBIZ Strong Buy
- Analyst Count
- MNMD 6
- FBIZ 4
- Target Price
- MNMD $24.67
- FBIZ $56.50
- AVG Volume (30 Days)
- MNMD 1.3M
- FBIZ 51.0K
- Earning Date
- MNMD 07-31-2025
- FBIZ 07-24-2025
- Dividend Yield
- MNMD N/A
- FBIZ 2.25%
- EPS Growth
- MNMD N/A
- FBIZ 22.54
- EPS
- MNMD N/A
- FBIZ 5.60
- Revenue
- MNMD N/A
- FBIZ $150,952,000.00
- Revenue This Year
- MNMD N/A
- FBIZ $18.39
- Revenue Next Year
- MNMD N/A
- FBIZ $7.81
- P/E Ratio
- MNMD N/A
- FBIZ $9.20
- Revenue Growth
- MNMD N/A
- FBIZ 8.24
- 52 Week Low
- MNMD $4.70
- FBIZ $39.65
- 52 Week High
- MNMD $10.44
- FBIZ $56.46
- Technical
- Relative Strength Index (RSI)
- MNMD 71.46
- FBIZ 35.75
- Support Level
- MNMD $9.54
- FBIZ $53.37
- Resistance Level
- MNMD $10.09
- FBIZ $54.49
- Average True Range (ATR)
- MNMD 0.47
- FBIZ 1.36
- MACD
- MNMD 0.18
- FBIZ -0.55
- Stochastic Oscillator
- MNMD 83.89
- FBIZ 1.43
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
About FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.